Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DR26FCK2B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467.00 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injections under a firm fixed-price contract type with no set-aside designation. The award was issued on October 22, 2025, with an ultimate completion date of October 23, 2025. SKYRIZI is a biologic medication used to treat inflammatory conditions including psoriasis and psoriatic arthritis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements across multiple therapeutic domains and transaction sizes.
Quick answers
Who was awarded contract SPE2DR26FCK2B?
SPE2DR26FCK2B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FCK2B worth?
The government has obligated $12,467 on SPE2DR26FCK2B.
Is contract SPE2DR26FCK2B an order under another contract?
Yes. SPE2DR26FCK2B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCK2B competed?
The extent of competition for SPE2DR26FCK2B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award